Welcome to the Altindis Lab
In the Altindis Lab, we adopt an interdisciplinary approach to address two complex and vital questions. Our primary objectives encompass: (a) characterizing the effects of viral insulin/IGF-1-like peptides (VILPs) on the insulin/IGF system and host-pathogen interactions, and (b) determining the role of the gut microbiome and microbiome-derived metabolites in Type 1 diabetes and celiac disease.
Our Research & Values
Characterization of Viral Insulin/IGF-1-like Peptides (VILPs)
Our recent and exciting discovery has unveiled that viruses carry sequences strikingly similar to human peptide hormones. Specifically, we™ve identified six VILPs within the Iridoviridae virus family. In this comprehensive project, our aim is to comprehend how VILPs interact with the insulin/IGF-1 system, influencing receptors, downstream signaling, and related functions. We™ve already uncovered unique functions of VILPs including IGF-1 receptor inhibition. Furthermore, we™re delving into the role of VILPs in host-pathogen interactions using the Grouper Iridovirus and zebrafish as model systems.Â
The Role of Gut Microbiome in Autoimmunity
As autoimmune diseases become more prevalent and genetics alone can™t explain their rise, attention has turned to environmental factors, including gut microbes and their products. We™re actively investigating the role of gut microbes and their products in the autoimmunity of Type 1 Diabetes and Celiac Disease. To explore this, we™re utilizing patient samples and mouse models of these diseases. Our focus includes understanding the molecular mimicry mechanism, examining specific bacterial species like Parabacteroides distasonis, and studying gut microbiota-derived metabolites. We™re also embracing innovative approaches like IgA-sequencing and Pep-Seq to deepen our understanding of the interactions between the microbiome and the host.
In this lab we believe:
- Science is realÂ
- Love is loveÂ
- Black lives matter
- Feminism is for everyone
- Cells are coolÂ
- Immigrants are welcome
More about what we do:
